Innovation transfer in the medical sector from clinics to companies
  • English
  • Polski
  • Deutsch
  • Magyar

Focus

Regions"The most important legislative instrument for the further development of health care in South Tyrol is the Provincial health plan. Following the European trend the Provincial health plan contains a list of regulations of a strategic nature, which aims to provide a steady improvement in the health system taking into account available resources. The Provincial health plan, in line with the State health plan and the aims of the World Health Organisation (WHO) emphasises the development of the health protection of the citizen as a fundamental right of the individual and an interest of the community in accordance with human dignity and freedom. Within the aims of that health policy the Plan highlights the following priorities: the fight against tumour-based diseases, the causes of death as a result of violence, and infectious diseases. Priorities are: protecting the health of the elderly, protection of mental health, the campaign against drugs and the misuse of medicine, and against heart and circulatory diseases."

 

Excerpt from : Evaluation of clinics in every region

Welcome to InTraMed-C2C!

InTraMed-C2C is a European project, with the participation of 7 countries and 10 project partners.


The project idea was born by the project partner Clusterland Upper Austria. They experienced that clinics have a high potential for innovations in product, process and service development in the overall medical industry, but this innovation potential is insufficiently transferred into results such as product development for companies, Intellectual Property (IP) generation and better healthcare processes.

 

InTraMed-C2C will initiate, develop and provide tools for strengthening the access of small and medium enterprises (local and European wide) to the innovation potential in the clinics.


One of the reasons for the insufficiently transferred results is that clinics and companies have different missions concerning handling innovative ideas. Clinics are “end-users” of innovations and clinics are also driving forces for bottom-up approaches of innovation transfer into the industry and their products. Companies, especially global players, are highly interested in providing their existing range of products to the clinics, new innovations are interesting only regarding the economic aspects. Moreover, these global players have established adequate access to the key functions in the clinics, supported by their distinctive marketing resources. As a result, global player dominate the supply of products and services in the clinics. Small and Medium Enterprises (SME) and developments initiated by the clinic staff often do not have the resources and chances to transfer their ideas and knowledge into adequate product developments.

 

InTraMed-C2C develops an innovation transfer system (“framework”) as an exchange and coordination mechanism for innovations in the medical/clinical sector between key players of the regional innovation environment. This innovation transfer system will be embedded in the regional innovation framework. With its trans-regional approach InTraMed-C2C will extend this framework beyond the regional approach in order to provide innovative ideas to companies for realizing these ideas within the system developed by the project. It is in the scope of the project to initiate a European network for Innovation transfer as an open exchange structure for innovations and their realizing companies and institutions within the Central Europe area.